Tomasz Z Jodlowski
Overview
Explore the profile of Tomasz Z Jodlowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
1462
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Conrad Z, Salazar A, Akers A, Jodlowski T, Wang L, Drechsler H, et al.
Fed Pract
. 2023 Sep;
40(5):146-151.
PMID: 37727509
Background: Accurate and timely prescriptions of COVID-19 therapeutics, laboratory testing, and antimicrobial stewardship have been a challenge throughout the pandemic as new evidence emerges. While universal consultation with infectious disease...
2.
Chiasson J, Smith W, Jodlowski T, Kouma M, Cutrell J
J Pharm Pract
. 2021 Apr;
35(5):722-729.
PMID: 33813935
Purpose: Utilization of rapid diagnostic testing alongside intensive antimicrobial stewardship interventions improves patient outcomes. We sought to determine the clinical impact of a rapid blood culture identification (BCID) panel in...
3.
Sanders J, Monogue M, Jodlowski T, Cutrell J
JAMA
. 2020 Apr;
323(18):1824-1836.
PMID: 32282022
Importance: The pandemic of coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented challenge to identify effective drugs for prevention and...
4.
White C, Jodlowski T, Atkins D, Holland N
J Pharm Pract
. 2016 Apr;
30(4):464-467.
PMID: 27071978
Objective: To report on a patient with a symptomatic, polymicrobial Escherichia coli and multidrug-resistant (MDR), extended-spectrum β-lactamase (ESBL)-positive Klebsiella pneumoniae urinary tract infection (UTI) who was successfully treated with oral...
5.
Jodlowski T, Sym D, Marziliano A, LaPan-Dennis G, Ashby Jr C, Ruhe J
J Pharm Pract
. 2015 Jan;
29(4):382-5.
PMID: 25613054
Purpose: To determine the methods used by pharmacists in academia to estimate kidney function for antimicrobial dosing. Methods: Stratified by region, a random sample of Accreditation Council for Pharmacy Education...
6.
Jodlowski T, Tam C
Ann Pharmacother
. 2014 Oct;
48(11):1533-4.
PMID: 25301828
Medication reconciliation is an important process to help reduce medication errors.1,2 Based on our experience, pharmacists enhance the medication reconciliation process in this high-risk group. However, such interventions need to...
7.
Li A, Zhao S, Jodlowski T
Ann Pharmacother
. 2011 Dec;
45(12):1591-2.
PMID: 22128045
No abstract available.
8.
Jodlowski T, Sym D, Conry J, Kanmaz T
J Pharm Pract
. 2011 Apr;
23(5):507-10.
PMID: 21507855
No abstract available.
9.
10.
Jodlowski T, Lam S, Ashby Jr C
Ann Pharmacother
. 2008 Oct;
42(11):1621-39.
PMID: 18845620
Objective: To describe emerging therapies, such as levofloxacin, moxifloxacin, rifabutin, rifaximin, tinidazole, doxycycline, minocycline, lactoferrin, and plaunotol for the eradication of Helicobacter pylori infection. Data Sources: Relevant information was identified...